募集资金使用
Search documents
聚石化学: 广东聚石化学股份有限公司前次募集资金使用情况的鉴证报告
Zheng Quan Zhi Xing· 2025-08-18 16:30
Core Viewpoint - The report provides an overview of the fundraising activities and the utilization of funds by Guangdong Jushi Chemical Co., Ltd., highlighting the total amount raised, expenses incurred, and the current status of the funds as of June 30, 2025 [1][2]. Fundraising Overview - The total amount raised through the initial public offering (IPO) was RMB 855.17 million, with net proceeds amounting to RMB 775.73 million after deducting issuance costs of RMB 79.44 million [2][3]. - The funds were fully deposited into a designated account approved by the board of directors, and a regulatory agreement was signed with the sponsoring institution and the bank [2][3]. Fund Utilization - As of June 30, 2025, the total amount utilized from the raised funds was RMB 796.85 million, with various deductions for underwriting fees, pre-invested funds, and temporary working capital [2][3]. - The company has also temporarily supplemented working capital with idle funds, amounting to RMB 47.58 million, which was returned to the designated account by August 2, 2023 [5][6]. Project Changes - The implementation subject and location for the "Halogen-free Flame Retardant Expansion Project" were changed from a subsidiary in Guangdong to another in Anhui due to local regulatory constraints [3][7]. - The "Poly Styrene Production Project" was also relocated from Anhui to a different site in Anhui, reflecting strategic adjustments based on land availability and logistical considerations [4][7]. Financial Management - The company has engaged in cash management with idle funds, investing a total of RMB 121 million in low-risk financial products, yielding a return of RMB 367,042.51 [5][6]. - The company has also utilized excess funds for permanent working capital supplementation, with a total of RMB 80 million allocated for this purpose [6][7]. Economic Benefits - The projects funded by the raised capital are expected to generate significant economic benefits, although some projects, such as those for working capital and R&D, do not yield direct financial returns [8][12]. - The production capacity and output from the projects have been monitored, with the "Modified Plastic Expansion Project" achieving a production output of 23,358.52 tons in 2023, with a capacity utilization rate of 58.40% [12].
禾丰股份: 禾丰股份第八届监事会第八次会议决议公告
Zheng Quan Zhi Xing· 2025-08-18 16:17
Core Viewpoint - The supervisory board of He Feng Food Co., Ltd. has approved the 2025 semi-annual report and related proposals, ensuring compliance with legal and regulatory requirements [1][2][3] Group 1: Semi-Annual Report - The supervisory board confirmed that the 2025 semi-annual report was prepared and reviewed in accordance with laws, regulations, and internal management systems [1] - The report accurately reflects the company's operational results and financial status for the first half of 2025 [1][2] - The voting results for the approval of the semi-annual report were 3 votes in favor, with no votes against or abstentions [2][3] Group 2: Fund Usage Report - The supervisory board approved the special report on the storage and actual use of raised funds for the first half of 2025 [2] - The voting results for this report were also 3 votes in favor, with no votes against or abstentions [2][3] Group 3: Fund Investment Projects - The supervisory board approved the conclusion and termination of the fundraising projects from the 2022 public offering of convertible bonds, reallocating part of the remaining funds to new investment projects [2] - This decision is seen as a cautious move to enhance the efficiency of fund usage and is in the interest of all shareholders [2] - The voting results for this proposal were 3 votes in favor, with no votes against or abstentions [2][3] - This proposal will require approval from the company's shareholders' meeting [3]
九丰能源: 第三届监事会第十二次会议决议公告
Zheng Quan Zhi Xing· 2025-08-18 09:12
成为最具价值创造力的清洁能源服务商 证券代码:605090 证券简称:九丰能源 公告编号:2025-067 江西九丰能源股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 江西九丰能源股份有限公司(以下简称"公司")第三届监事会第十二次会议于 2025 年 8 月 18 日(星期一)以现场表决方式召开。会议通知于 2025 年 8 月 8 日(星期五) 以电子邮件等方式送达全体监事。本次会议应出席监事 3 人,实际出席监事 3 人,会议 由监事会主席慕长鸿先生召集和主持。本次会议的召集、召开及表决程序符合有关法律 法规和《公司章程》的相关规定。 二、监事会会议审议情况 经与会监事认真审议,本次会议逐项表决通过以下决议: 具体内容详见同日在上海证券交易所网站(www.sse.com.cn)披露的《2025 年半年 度报告》及《2025 年半年度报告(摘要)》。 表决结果:3 票同意、0 票反对、0 票弃权。 (二)审议通过《关于 2025 年半年度利润分配方案的议案》 (一)审议通过《关于<20 ...
华之杰: 中信建投证券股份有限公司关于苏州华之杰电讯股份有限公司使用自有资金及银行承兑汇票等方式支付募投项目部分款项并以募集资金等额置换的核查意见
Zheng Quan Zhi Xing· 2025-08-17 16:11
Core Viewpoint - The company, Suzhou Huazhijie Electric Co., Ltd., is utilizing its own funds and bank acceptance bills to pay for part of the fundraising investment projects and will replace these with the raised funds in an equal amount, which is deemed beneficial for improving fund utilization efficiency and reducing financial costs [1][6][8]. Fundraising Basic Situation - The company has received approval from the China Securities Regulatory Commission for its initial public offering (IPO) and has issued 25,000,000 shares at a price of RMB 19.88 per share, raising a total of RMB 444,164,357.75 [1][2]. Investment Project Situation - The total investment for the annual production of 86.5 million intelligent components for electric tools is RMB 48,608.58 million, with an adjusted fundraising amount of RMB 44,416.44 million [2]. Reasons for Using Own Funds - The company needs to use its own funds and bank acceptance bills for initial payments due to regulatory requirements regarding salary payments, tax obligations, and operational efficiency [3][4][5]. Replacement Process of Raised Funds - The company will establish a detailed ledger and summary table for payments made with its own funds and will apply for the replacement of these amounts with raised funds on a monthly basis, following internal approval processes [4][5]. Impact on the Company - The approach of using own funds and bank acceptance bills is expected to enhance the efficiency of fund utilization, lower financial costs, and will not affect the normal operation of the company or the implementation of fundraising projects [5][6]. Review Procedures - The company’s board of directors has approved the use of own funds and bank acceptance bills for project payments, ensuring compliance with relevant laws and regulations [6][7]. Sponsor's Verification Opinion - The sponsor, CITIC Construction Investment Securities Co., Ltd., has verified that the company's actions do not alter the direction of the raised funds and are in compliance with legal requirements, supporting the normal progress of the fundraising projects [6][7].
北京信安世纪科技股份有限公司第三届监事会第十次会议决议公告
Shang Hai Zheng Quan Bao· 2025-08-15 19:42
Group 1 - The third meeting of the Supervisory Board of Beijing Xinan Century Technology Co., Ltd. was held on August 15, 2025, with all five supervisors present [2][3] - The meeting approved the special report on the use of previously raised funds, which reflects the company's fund usage as of March 31, 2025, in compliance with relevant laws and regulations [2][6] - The company raised a total of approximately RMB 623.49 million through the issuance of 23,281,939 shares at a price of RMB 26.78 per share, with a net amount of RMB 561.76 million after deducting issuance costs [6] Group 2 - The company has established a management system for the raised funds, ensuring compliance with regulations and proper usage [7] - As of March 31, 2025, the company had no outstanding balance of idle raised funds for cash management [21] - The company plans to apply for a comprehensive credit limit of up to RMB 50 million from China Minsheng Bank to support its operational needs [28][29]
必易微: 申万宏源证券承销保荐有限责任公司关于深圳市必易微电子股份有限公司使用募集资金向全资子公司实缴出资和提供借款以实施募投项目的核查意见
Zheng Quan Zhi Xing· 2025-08-15 16:35
Summary of Key Points Core Viewpoint - The company, Shenzhen Biyi Microelectronics Co., Ltd., is utilizing raised funds to make capital contributions and provide loans to its wholly-owned subsidiary for the implementation of investment projects, specifically the "Power Management Series Control Chip Development and Industrialization Project" [1][9]. Fundraising Overview - The company successfully raised a total of RMB 95,201.58 million by issuing 17,262,300 shares at RMB 55.15 per share, with a net amount of RMB 86,077.79 million after deducting issuance costs [1][2]. Investment Project Details - The total investment amount for the fundraising projects is RMB 65,251.50 million, with the "Biyi Micro R&D Center Construction Project" already completed and reaching a usable state [3][4]. Use of Funds for Subsidiary - The company plans to use RMB 5,000 million for capital contributions and up to RMB 3,000 million as interest-free loans to its subsidiary, Biyi Micro Shanghai, for the development and industrialization of power management chips [4][5][6]. Management of Raised Funds - A dedicated fund account will be established for the project, ensuring that the funds are used solely for the intended purpose, in compliance with relevant regulations [6][7]. Approval Process - The board of directors and the supervisory board have approved the use of funds, confirming that it aligns with legal requirements and does not alter the intended use of the raised funds [7][8][9].
科兴制药: 中信建投证券股份有限公司关于科兴生物制药股份有限公司使用部分募集资金向全资子公司提供无息借款以实施募投项目的核查意见
Zheng Quan Zhi Xing· 2025-08-15 16:24
Summary of Key Points Core Viewpoint - The company plans to use part of the raised funds to provide interest-free loans to its wholly-owned subsidiary for the implementation of fundraising projects, which has been reviewed and approved by the sponsor institution [1][9]. Fundraising Overview - The company raised a total of RMB 1,109.25 million through its initial public offering, with a net amount of RMB 994.64 million after deducting issuance costs [1]. - The total planned investment for the fundraising projects is RMB 1,771.79 million, with the company intending to allocate RMB 994.64 million from the raised funds [2]. Use of Funds - The company previously provided an interest-free loan of RMB 50 million to its subsidiary Shenzhen Kexing Pharmaceutical for the "R&D Center Upgrade Project" [2][3]. - The current plan includes an additional interest-free loan of RMB 20 million to the same subsidiary for ongoing R&D projects, bringing the total loan amount to RMB 120 million [4][5]. Project Progress - As of June 30, 2025, the cumulative investment in the R&D Center Upgrade Project is RMB 347.46 million, with RMB 290.63 million already utilized, resulting in a shortfall of RMB 56.83 million [4]. - The remaining balance in the dedicated fundraising account for this project is RMB 73.96 million, which includes net income from financial products and bank interest [4]. Financial Data of the Subsidiary - As of December 31, 2024, the subsidiary reported total assets of RMB 535.61 million, net assets of RMB 278.31 million, operating income of RMB 316.77 million, and net profit of RMB 51.75 million [7]. Approval Process - The use of funds for the interest-free loan has been approved by the company's board and supervisory board, complying with relevant regulations [9].
农发种业: 中农发种业集团股份有限公司关于无需编制前次募集资金使用情况报告的公告
Zheng Quan Zhi Xing· 2025-08-15 11:17
根据中国证监会发布的《监管规则适用指引——发行类第 7 号》有关规定: "前次募集资金使用情况报告对前次募集资金到账时间距今未满五个会计年度 的历次募集资金实际使用情况进行说明,一般以年度末作为报告出具基准日,如 截止最近一期末募集资金使用发生实质性变化,发行人也可提供截止最近一期末 经鉴证的前募报告。" 证券代码:600313 证券简称:农发种业 公告编号:临 2025-026 中农发种业集团股份有限公司 关于无需编制前次募集资金使用情况报告的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、公司最近五年不存在募集资金的情况 中农发种业集团股份有限公司(以下简称"公司")于 2025 年 8 月 15 日召 开了第七届董事会第五十次会议,审议通过了关于公司向特定对象发行 A 股股票 的相关议案。 公司最近五个会计年度不存在通过配股、增发、发行可转换公司债券等方式 募集资金的情况,公司前次募集资金到账至今已超过五个会计年度且已经全部使 用完毕。因此,公司本次向特定对象发行股票无需编制前次募集资金使用情况的 报告,亦无需 ...
苏州西典新能源电气股份有限公司2025年半年度报告摘要
Shang Hai Zheng Quan Bao· 2025-08-14 19:12
Core Viewpoint - The company, Suzhou Xidian New Energy Electric Co., Ltd., has announced its 2025 mid-term profit distribution plan, proposing a cash dividend of 4.00 RMB per 10 shares, totaling approximately 62.74 million RMB, which represents 45.13% of the net profit attributable to shareholders for the first half of 2025 [25][26][28]. Group 1: Company Overview - The company is planning to establish a wholly-owned subsidiary named Suzhou Xidian New Energy Technology Co., Ltd. with a registered capital of 100 million RMB to enhance its technological product development [31][32]. - The company has also proposed to increase the registered capital of its wholly-owned subsidiary, Suzhou Xidian New Energy Automotive Electronics Co., Ltd., from 50 million RMB to 150 million RMB to support the implementation of fundraising projects [39][40]. Group 2: Financial Data - As of June 30, 2025, the company reported a net profit attributable to shareholders of 139.03 million RMB for the first half of 2025, with distributable profits amounting to 207.42 million RMB [26][28]. - The total share capital of the company is 161.6 million shares, with 4.75 million shares held in a repurchase account excluded from the dividend calculation [26][27]. Group 3: Board Meeting Decisions - The second board meeting on August 14, 2025, approved several key proposals, including the mid-term profit distribution plan, the establishment of a wholly-owned subsidiary, and the increase of capital for the subsidiary [5][6][8]. - The board also approved the use of self-owned funds to pay for part of the fundraising project costs, which will later be replaced with the raised funds [53][55]. Group 4: Audit and Compliance - The company has proposed to renew its audit engagement with Rongcheng Accounting Firm for the 2025 fiscal year, pending shareholder approval [62][75]. - The audit committee has reviewed and approved the renewal, confirming the firm's qualifications and independence [74][75]. Group 5: Employee Stock Ownership Plan - The board has approved the distribution of reserved shares under the first employee stock ownership plan, which does not require shareholder approval [79]. - This plan aims to align employee interests with company performance and enhance retention [79].
深圳微芯生物科技股份有限公司前次募集资金使用情况的专项报告
Shang Hai Zheng Quan Bao· 2025-08-14 19:01
Group 1 - The company raised a total of RMB 500 million through the issuance of 5 million convertible bonds, with a net amount of RMB 484.54 million after deducting issuance costs of RMB 15.46 million [2][3] - The funds were fully received on July 11, 2022, and verified by KPMG Huazhen [2] - As of March 31, 2025, the company reported no surplus in the use of the raised funds [13] Group 2 - The company adjusted its investment projects to meet market demand for Seglitazone, reallocating funds from the original CS12192 project to the Seglitazone production facilities [4] - The total actual investment in the projects may differ from the committed amounts, with details provided in the attached tables [5][14] - The company has utilized RMB 73.72 million of the raised funds to replace pre-invested self-raised funds for the investment projects [6] Group 3 - The company has engaged in cash management of temporarily idle funds, with a maximum of RMB 300 million allocated for safe and liquid investment products [9][10][11] - As of March 31, 2025, the company reported on the management of temporarily idle funds [12] Group 4 - The company will hold an online investor briefing on August 27, 2025, to discuss its half-year results and address investor questions [17][18] - The briefing will be conducted via the Shanghai Stock Exchange Roadshow Center, allowing for interactive communication with investors [18][19]